Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
temporality | order of exposure and subsequent change | The temporality supports consideration of a drug reaction. | Assessment | Diagnostic attribution and strength of evidence |
therapeutic index | measure of separation between effective and toxic doses or exposures | The drug's narrow therapeutic index informs the monitoring plan. | Assessment | Drug levels - exposure and pharmacokinetics |
therapeutic window | range of exposure between desired effect and unacceptable toxicity in context | The narrow therapeutic window makes accurate sampling particularly important. | Assessment | Drug levels - exposure and pharmacokinetics |
tolerance | reduced effect with repeated exposure in this context | Loss of effect over repeated use raises the question of pharmacologic tolerance. | Assessment | Risk, goals, medication assessment and function |
toxic | related to harmful exposure | Recent solvent exposure raises concern for a toxic contribution. | Assessment | Cause and mechanism |
toxicology consult | request for specialist review of a possible toxic exposure | Record the clinical question for the toxicology consult. | Plan | Monitoring actions, escalation and result communication |
toxidrome | recognizable cluster of findings associated with a class of toxic exposures | The consultant evaluated the findings for a recognizable toxidrome. | Assessment | Medication exposure, response and adverse-effect reasoning |
vancomycin | glycopeptide antibiotic measured for exposure monitoring in selected settings | The vancomycin report lists a measured concentration and a separate estimated AUC24. | Objective | Drug levels - named analytes and exposure reports |
| became less intense or stopped | Reports that the cramps abated after resting. | Subjective | Sequence, exposures and use of medicines | |
above target | exceeds the applicable stated goal | The verified predose level was above target for the documented treatment phase. | Assessment | Drug levels - exposure and pharmacokinetics |
absolute bioavailability | systemic availability relative to an intravenous reference with dose adjustment | The study estimated absolute bioavailability using paired oral and intravenous data. | Assessment | Drug concentrations, exposure and assay interpretation |
absorption interaction | coadministration changes how much or how quickly a dose is absorbed | The absorption interaction was considered after reviewing timing with minerals and meals. | Assessment | Medication response, exposure and reconciliation |
absorption lag time | delay between dosing and the start of measurable absorption in a model | The model includes an absorption lag time before concentrations begin to rise. | Assessment | Drug concentrations, exposure and assay interpretation |
absorption rate constant | parameter describing the rate of absorption in a specified model | The fitted absorption rate constant was reported with its units and model assumptions. | Assessment | Drug concentrations, exposure and assay interpretation |
accelerated | increased in speed or frequency | Reports that the decline in walking tolerance accelerated this month. | Subjective | Sequence, exposures and use of medicines |
active moiety | component responsible for pharmacologic activity in context | The report specifies which active moiety the assay measures. | Assessment | Medication exposure, response and adverse-effect reasoning |
activity-related | associated with physical activity | Reports activity-related swelling after longer walks. | Subjective | Sequence, exposures and use of medicines |
activity pacing | spacing tasks and rest periods to manage symptoms | The patient reports activity pacing when preparing meals or doing laundry. | Subjective | Activities, exposure and recovery history |
additive risk | two or more factors may increase the same adverse outcome | The assessment notes additive risk of sedation from the combination. | Assessment | Medication exposure, response and adverse-effect reasoning |
additive sedation | two or more agents may increase sedation through combined effects | Additive sedation was considered after the bedtime regimen changed. | Assessment | Medication response, exposure and reconciliation |
adherence estimate | approximation of actual use based on a stated source | The adherence estimate was based on refill dates and checked against the patient's account. | Assessment | Medication response, exposure and reconciliation |
administration discrepancy | difference between a written order and the actual administration | The administration discrepancy involved the evening dose recorded on the transfer sheet. | Assessment | Medication response, exposure and reconciliation |
adverse reaction | harmful unintended response attributed or suspected to be related to a drug | The timing raises concern for an adverse reaction, with causality under review. | Assessment | Medication exposure, response and adverse-effect reasoning |
Allergic rhinitis | Hay fever | The assessment includes allergic rhinitis with symptoms tracking pollen exposure. | Assessment | Inflammatory, immune and endocrine assessment |
amikacin | aminoglycoside with drug- and regimen-specific concentration targets | The amikacin concentration is documented with the dialysis session time. | Objective | Drug levels - named analytes and exposure reports |